Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives
Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid progression, early metastasis, and high recurrence rates. Historically considered a homogeneous disease, recent multi-omic studies have revealed distinct molecular subtypes driven by lineage-defining transcription...
Saved in:
| Main Authors: | Daoyuan Huang, Jingchao Wang, Li Chen, Weiwei Jiang, Hiroyuki Inuzuka, David K. Simon, Wenyi Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/8/1731 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promoters of ASCL1‐ and NEUROD1‐dependent genes are specific targets of lurbinectedin in SCLC cells
by: Federico Costanzo, et al.
Published: (2022-03-01) -
Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma
by: Keiichiro Kitahama, et al.
Published: (2025-04-01) -
An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis
by: Xiaolu Yang, et al.
Published: (2025-02-01) -
Reevaluating the role of Pou3f1 in striatal development: Evidence from transgenic mouse models
by: Xiaolei Song, et al.
Published: (2025-05-01) -
Exploring the functional role of POU5F1 using CRISPR RNP electroporation of zygote (CRISPR-EZ) in buffaloes
by: Meeti Punetha, et al.
Published: (2023-11-01)